Ark Bio

company

About

Ark Bio is a medical technology company

  • 11 - 50

Details

Last Funding Type
Series A
Last Funding Money Raised
$40M
Industries
Biotechnology,Medical
Founded date
Jan 1, 2018
Number Of Employee
11 - 50
Operating Status
Active

Ark is an end-to-end solution provider focused on cancer early detection. By harnessing advanced data science and proprietary miRNA detection technology, Ark develops non-invasive and cost-effective blood tests to detect early stage cancers before clinical symptoms appear. The company collaborates extensively with top medical research institutions globally and is spearheading Asia’s largest miRNA clinical studies targeting more than 50,000 participants. Ark is headquartered in Singapore, with R&D, manufacturing and clinical diagnostic operations in China and USA.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$40M
Ark Bio has raised a total of $40M in funding over 2 rounds. Their latest funding was raised on Nov 27, 2018 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Nov 27, 2018 Series A $40M 1 Gaorong Capital Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Ark Bio is funded by 1 investors. Gaorong Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Gaorong Capital Yes Series A